A detailed history of Haven Private, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Haven Private, LLC holds 1,182 shares of ABBV stock, worth $234,095. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,182
Holding current value
$234,095
% of portfolio
0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025

BUY
$170.16 - $206.27 $201,129 - $243,811
1,182 New
1,182 $219 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $350B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Haven Private, LLC Portfolio

Follow Haven Private, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haven Private, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Haven Private, LLC with notifications on news.